Roth Capital Reiterates Buy on SANUWAVE Health, Lowers Price Target to $47

Benzinga Newsdesk www.benzinga.com Negative 86.1%

Neg 86.1% Neu 0% Pos 0%

Roth Capital analyst Kyle Bauser reiterates SANUWAVE Health (NASDAQ:SNWV) with a Buy and lowers the price target from $53 to $47.